Belhassen Laurent, Carville Claudine, Pelle Gabriel, Monin Jean Luc, Teiger Emmanuel, Duval-Moulin Anne Marie, Dupouy Patrick, Dubois Rande Jean Luc, Gueret Pascal
Service de Physiologie-Explorations Fonctionnelles, Henri-Mondor University Hospital, APHP, Créteil, France.
J Am Coll Cardiol. 2002 Apr 3;39(7):1139-44. doi: 10.1016/s0735-1097(02)01748-5.
We assessed the value of carotid intima-media thickness (CIMT) and thoracic aorta intima-media thickness (AoIMT) in ruling out significant coronary artery disease (CAD) in patients scheduled for heart valve surgery.
Evaluation of CAD is needed in most patients undergoing heart valve surgery because of the high surgical morbidity in patients with significant CAD, raising the need for sensitive tests to exclude CAD. Coronary angiography is the reference standard, but this invasive procedure is not cost-effective, because more than two-thirds of these patients do not have significant CAD.
In a pilot study, CIMT and AoIMT cutoff values separating low- from high-risk groups were determined in 96 patients by using receiver-operating characteristic curves. Then, a prospective study was conducted in 152 patients to determine the statistical power of these cutoff values used alone or in combination. In both studies, carotid artery ultrasonography and transesophageal echocardiography were performed before coronary angiography and valve surgery.
In the pilot study, CIMT < 0.55 mm and AoIMT < 3 mm were excellent predictors of the absence of CAD. In the prospective study, CIMT and AoIMT criteria were independent predictors of significant CAD in these patients, as assessed by logistic regression analysis. Carotid IMT criterion had 100% sensitivity and 100% negative predictive value. For the AoIMT criterion, sensitivity was 98%, and negative predictive value 99%. Combining the two criteria did not change sensitivity and negative predictive value but increased specificity to 78%.
Measurements of CIMT and AoIMT may be useful in selecting patients who do not require coronary angiography before heart valve surgery.
我们评估了颈动脉内膜中层厚度(CIMT)和胸主动脉内膜中层厚度(AoIMT)在排除计划进行心脏瓣膜手术患者的严重冠状动脉疾病(CAD)方面的价值。
大多数接受心脏瓣膜手术的患者都需要评估CAD,因为患有严重CAD的患者手术并发症发生率高,因此需要敏感的检测方法来排除CAD。冠状动脉造影是参考标准,但这种侵入性检查不具有成本效益,因为这些患者中超过三分之二没有严重CAD。
在一项初步研究中,通过使用受试者操作特征曲线,在96例患者中确定了区分低风险组和高风险组的CIMT和AoIMT临界值。然后,对152例患者进行了一项前瞻性研究,以确定单独或联合使用这些临界值的统计效力。在这两项研究中,在冠状动脉造影和瓣膜手术前进行了颈动脉超声检查和经食管超声心动图检查。
在初步研究中,CIMT<0.55mm和AoIMT<3mm是无CAD的优秀预测指标。在前瞻性研究中,通过逻辑回归分析评估,CIMT和AoIMT标准是这些患者严重CAD的独立预测指标。颈动脉内膜中层厚度标准的敏感性为100%,阴性预测值为100%。对于AoIMT标准,敏感性为98%,阴性预测值为99%。联合这两个标准并没有改变敏感性和阴性预测值,但特异性提高到了78%。
测量CIMT和AoIMT可能有助于选择在心脏瓣膜手术前不需要进行冠状动脉造影的患者。